Methylfolate 1333 mcg DFE (800 mcg (6S)-5-Methyltetrahydrofolate) Orange Flavor
Product analysis
Methylfolate 1333 mcg DFE (800 mcg (6S)-5-Methyltetrahydrofolate) Orange Flavor provides folate that supports normal blood formation when intake is low.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
The folate source is clearly identified as methylfolate glucosamine salt. The form alone does not establish better health outcomes.
Ingredient Transparency100
The folate amount and specific form are disclosed. That makes the serving straightforward to identify and compare.
Value For Money100
The methylfolate serving offers good value in the available cost comparison. The form does not establish an additional benefit simply because it is clearly identified.
Customer Satisfaction83
Customer feedback is very positive across several hundred ratings. The review base gives a useful picture of satisfaction.
Product Focus75
The clearest use is meeting folate needs for normal metabolism and blood formation. The high amount does not establish extra benefit when intake is adequate or an independent hair-growth effect.
- Format
Tablet - Container
- 60 Tablet(s)
- Per serving
- $0.28
- Customer rating
- 4.9 · 887 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Folate ((6S)-5-Methyltetrahydrofolate-Glucosamine Salt) | 1333 mcg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Intakes of Folate, Vitamin B6, and Vitamin B12 in Relation to All-Cause and Cause-Specific Mortality: A National Population-Based Cohort.
- The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study.
- Associations of Serum Folate and Homocysteine Concentrations with All-Cause, Cardiovascular Disease, and Cancer Mortality in Men and Women in Korea: the Cardiovascular Disease Association Study.
- The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA.
- Systematic review of adverse health outcomes associated with high serum or red blood cell folate concentrations.
- Hair Loss After Metabolic and Bariatric Surgery: a Systematic Review and Meta-analysis.
- Quantitative Analysis of Selected Circulating Hematological Biomarkers, Essential Minerals, Vitamins, and Thyroid Hormones in Females Affected by Hair Loss.
- Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.
- Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
- Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.